Related Articles
The role of components of the chromatin modification machinery in carcinogenesis of clear cell carcinoma of the ovary (Review)
ARID1A gene mutation in ovarian and endometrial cancers (Review)
ARID1A restrains EMT and stemness of ovarian cancer cells through the Hippo pathway
Diagnostic significance and prognostic role of the ARID1A gene in cancer outcomes (Review)
Gene amplification of chromatin remodeling factor <em>SMARCC2</em> and low protein expression of ACTL6A are unfavorable factors in ovarian high‑grade serous carcinoma